Our genes encode for about 20,000 different proteins that are the machinery of life. Nearly all new proteins are chemically modified in different ways to control how, when, and where they work. Prof Hogg, Head of the Centenary Cancer Stream and ACRF-Centenary Cancer Centre, discovered a new type of chemical modification of proteins that appears to be important for all life forms. He has used this knowledge to develop potential new therapies for cancer. The Federation of American Societies for Experimental Biology (FASEB) is hosting the first dedicated scientific meeting on this chemical modification later this month in Colorado, USA. FASEB is made up of 30 scientific member societies, representing over 125,000 researchers from around the world. Prof Hogg will be chairing the inaugural meeting. This is a very significant milestone for Prof Hogg and the research field.